Jocil Ltd (JOCIL) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 174867,
    "name": "Jocil",
    "stock_name": "Jocil",
    "full_name": "Jocil Ltd",
    "name_url": "stocks-analysis/jocil",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "150.85",
    "chg": -3.17,
    "chgp": "-2.06%",
    "dir": -1,
    "prev_price": "154.02",
    "mcapval": "133.97 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "JOCIL",
    "ind_name": "Chemicals & Petrochemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE839G01010",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": 3666,
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jocil-174867-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Jocil Sees Revision in Market Evaluation Amid Mixed Financial Indicators",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jocil-upgraded-from-strong-sell-to-sell-by-marketsmojo-on-3-feb-2025-3748290",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Jocil_mojoScore_3748290.png",
        "date": "2025-12-05 10:10:27",
        "description": "Jocil, a microcap player in the Chemicals & Petrochemicals sector, has experienced a revision in its market evaluation metrics, reflecting nuanced shifts across key financial and technical parameters. This adjustment comes amid a backdrop of subdued stock performance and sector-specific challenges."
      },
      {
        "title": "Is Jocil overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-jocil-overvalued-or-undervalued-3668624",
        "imagepath": "",
        "date": "2025-11-04 08:05:43",
        "description": "As of 3 November 2025, Jocil's valuation grade has moved from very expensive to expensive, indicating a slight improvement but still reflecting a high valuation relative to its fundamentals. The company is currently considered overvalued, supported by a PE ratio of 70.49, an EV to EBIT of 62.69, and a PEG ratio of 6.78, all of which are significantly higher than industry norms.\n\nIn comparison to its peers, Jocil's PE ratio is notably higher than Godrej Industries, which has a PE of 37.65 and is classified as attractive, and Deepak Nitrite, which is also expensive at a PE of 38.97. Additionally, Jocil's EV to EBITDA ratio of 12.61 is elevated compared to Godrej Industries' 29.75, further emphasizing its overvaluation. Recent stock performance shows Jocil underperforming against the Sensex over the year, with a return of -24.41% compared to the Sensex's 6.00%, reinforcing the notion that the stock may be over..."
      },
      {
        "title": "How has been the historical performance of Jocil?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-jocil-3668021",
        "imagepath": "",
        "date": "2025-11-03 22:47:37",
        "description": "Answer:\nThe historical performance of Jocil shows fluctuating trends in key financial metrics over the years.\n\nBreakdown:\nJocil's net sales increased from 753.20 Cr in Mar'24 to 865.54 Cr in Mar'25, following a dip to 753.59 Cr in Mar'22 and a peak of 919.28 Cr in Mar'23. Total operating income mirrored this trend, rising to 865.54 Cr in Mar'25 from 753.20 Cr in Mar'24. However, total expenditure also increased to 860.25 Cr in Mar'25 from 748.08 Cr in Mar'24, leading to an operating profit (PBDIT) of 7.24 Cr in Mar'25, down from 9.08 Cr in Mar'24. Profit before tax similarly declined to 1.34 Cr in Mar'25 from 2.65 Cr in Mar'24, resulting in a profit after tax of 1.02 Cr in Mar'25, compared to 1.73 Cr in Mar'24. The company's earnings per share (EPS) dropped to 1.15 in Mar'25 from 1.95 in Mar'24. On the balance sheet, total assets rose to 287.67 Cr in Mar'25 from 278.70 Cr in Mar'24, while total liabilities ..."
      },
      {
        "title": "Are Jocil latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-jocil-latest-results-good-or-bad-3667516",
        "imagepath": "",
        "date": "2025-11-03 19:14:18",
        "description": "Jocil's latest financial results for Q2 FY26 reveal a complex operational landscape characterized by both year-on-year growth and sequential declines. The company reported net sales of ₹245.78 crores, reflecting a 6.98% increase compared to the same quarter last year, but a notable 8.95% decrease from the previous quarter. This inconsistency in revenue generation indicates operational challenges that the company is currently facing.\n\nIn terms of profitability, Jocil's net profit amounted to ₹1.87 crores, which represents a significant year-on-year improvement of 62.61% from ₹1.15 crores in Q2 FY24. However, this figure also marks a 15.77% decline from the preceding quarter's net profit of ₹2.22 crores, highlighting difficulties in sustaining profit levels across consecutive quarters.\n\nThe operating margin for the quarter was reported at 1.48%, showing a slight improvement from 1.39% in the previous quarter ..."
      },
      {
        "title": "Jocil Faces Financial Health Challenges Amidst Mixed Earnings Performance and Market Disparities",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jocils-financial-trend-declines-from-flat-to-negative-amid-cash-flow-challenges-3666945",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Jocil_fintrenddot_3666945.png",
        "date": "2025-11-03 16:00:07",
        "description": "Jocil, a microcap in the Chemicals and Petrochemicals sector, reported a flat performance for the quarter ending September 2025. Despite a higher profit after tax of Rs 4.09 crore, challenges remain with low operating cash flow and a dividend per share of Rs 0.50, indicating operational inefficiencies."
      },
      {
        "title": "Jocil Q2 FY26: Margin Pressures Persist Despite Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/jocil-q2-fy26-margin-pressures-persist-despite-revenue-growth-3666845",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Jocil_quaterlyResult_3666845.png",
        "date": "2025-11-03 14:31:47",
        "description": "Jocil Ltd., a specialty chemicals manufacturer engaged in stearic acid, fatty acids, and refined glycerine production, reported a mixed performance for Q2 FY26, with net profit declining 15.77% quarter-on-quarter to ₹1.87 crores despite revenue growth. The Andhra Pradesh-based company, with a market capitalisation of ₹135.00 crores, continues to grapple with margin compression that has plagued its operations throughout FY25. The stock has declined 23.71% over the past year, significantly underperforming both the Sensex and its chemicals sector peers, whilst trading at elevated valuations that raise serious questions about its investment merit."
      },
      {
        "title": "Why is Jocil falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-jocil-fallingrising-3532813",
        "imagepath": "",
        "date": "2025-09-18 21:54:28",
        "description": "As of 18-Sep, Jocil Ltd's stock price is currently at 154.04, reflecting a decrease of 2.12, or 1.36%. The stock has underperformed its sector today by 0.86%, and it is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, Jocil has seen a return of -4.86%, while its performance over the last month is also negative at -3.91%. Despite a recent rise in delivery volume by 23.13%, the stock has experienced significant long-term challenges, including a decline in operating profit by an annual rate of -59.68% over the last five years and a return of -28.02% in the past year, indicating persistent underperformance against the benchmark.\n\nIn the broader market context, Jocil's recent performance contrasts sharply with the Sensex, which has gained 1.67% over the past week and 2.20% over the past month. The stock's long-term growth prospects appear poor, as evidenced ..."
      }
    ],
    "total": 5293,
    "sid": "174867",
    "stock_news_url": "https://www.marketsmojo.com/news/jocil-174867"
  },
  "announcements": [
    {
      "details": "Credit Rating Revision in ratings",
      "source": "NSE",
      "caption": "Jocil Limited - Credit Rating",
      "datetime": "26-Nov-2019"
    },
    {
      "details": "Jocil Limited has informed the Exchange regarding Board meeting held on November 02, 2019.",
      "source": "NSE",
      "caption": "Jocil Limited - Outcome of Board Meeting",
      "datetime": "04-Nov-2019"
    },
    {
      "details": " <table><tr><td>Jocil Limited has informed the Exchange regarding voting results of Annual General Meeting held on September 21, 2019 </td></tr></table>",
      "source": "NSE",
      "caption": "Shareholders meeting",
      "datetime": "21-Sep-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jocil Ltd has declared <strong>5%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Jocil Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 27 Sep 11",
          "dt": "2011-09-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Jocil Sees Revision in Market Evaluation Amid Mixed Financial Indicators

2025-12-05 10:10:27

Jocil, a microcap player in the Chemicals & Petrochemicals sector, has experienced a revision in its market evaluation metrics, reflecting nuanced shifts across key financial and technical parameters. This adjustment comes amid a backdrop of subdued stock performance and sector-specific challenges.

Is Jocil overvalued or undervalued?

2025-11-04 08:05:43

As of 3 November 2025, Jocil's valuation grade has moved from very expensive to expensive, indicating a slight improvement but still reflecting a high valuation relative to its fundamentals. The company is currently considered overvalued, supported by a PE ratio of 70.49, an EV to EBIT of 62.69, and a PEG ratio of 6.78, all of which are significantly higher than industry norms. In comparison to its peers, Jocil's PE ratio is notably higher than Godrej Industries, which has a PE of 37.65 and is classified as attractive, and Deepak Nitrite, which is also expensive at a PE of 38.97. Additionally, Jocil's EV to EBITDA ratio of 12.61 is elevated compared to Godrej Industries' 29.75, further emphasizing its overvaluation. Recent stock performance shows Jocil underperforming against the Sensex over the year, with a return of -24.41% compared to the Sensex's 6.00%, reinforcing the notion that the stock may be over...

How has been the historical performance of Jocil?

2025-11-03 22:47:37

Answer: The historical performance of Jocil shows fluctuating trends in key financial metrics over the years. Breakdown: Jocil's net sales increased from 753.20 Cr in Mar'24 to 865.54 Cr in Mar'25, following a dip to 753.59 Cr in Mar'22 and a peak of 919.28 Cr in Mar'23. Total operating income mirrored this trend, rising to 865.54 Cr in Mar'25 from 753.20 Cr in Mar'24. However, total expenditure also increased to 860.25 Cr in Mar'25 from 748.08 Cr in Mar'24, leading to an operating profit (PBDIT) of 7.24 Cr in Mar'25, down from 9.08 Cr in Mar'24. Profit before tax similarly declined to 1.34 Cr in Mar'25 from 2.65 Cr in Mar'24, resulting in a profit after tax of 1.02 Cr in Mar'25, compared to 1.73 Cr in Mar'24. The company's earnings per share (EPS) dropped to 1.15 in Mar'25 from 1.95 in Mar'24. On the balance sheet, total assets rose to 287.67 Cr in Mar'25 from 278.70 Cr in Mar'24, while total liabilities ...

Are Jocil latest results good or bad?

2025-11-03 19:14:18

Jocil's latest financial results for Q2 FY26 reveal a complex operational landscape characterized by both year-on-year growth and sequential declines. The company reported net sales of ₹245.78 crores, reflecting a 6.98% increase compared to the same quarter last year, but a notable 8.95% decrease from the previous quarter. This inconsistency in revenue generation indicates operational challenges that the company is currently facing. In terms of profitability, Jocil's net profit amounted to ₹1.87 crores, which represents a significant year-on-year improvement of 62.61% from ₹1.15 crores in Q2 FY24. However, this figure also marks a 15.77% decline from the preceding quarter's net profit of ₹2.22 crores, highlighting difficulties in sustaining profit levels across consecutive quarters. The operating margin for the quarter was reported at 1.48%, showing a slight improvement from 1.39% in the previous quarter ...

Jocil Faces Financial Health Challenges Amidst Mixed Earnings Performance and Market Disparities

2025-11-03 16:00:07

Jocil, a microcap in the Chemicals and Petrochemicals sector, reported a flat performance for the quarter ending September 2025. Despite a higher profit after tax of Rs 4.09 crore, challenges remain with low operating cash flow and a dividend per share of Rs 0.50, indicating operational inefficiencies.

Jocil Q2 FY26: Margin Pressures Persist Despite Revenue Growth

2025-11-03 14:31:47

Jocil Ltd., a specialty chemicals manufacturer engaged in stearic acid, fatty acids, and refined glycerine production, reported a mixed performance for Q2 FY26, with net profit declining 15.77% quarter-on-quarter to ₹1.87 crores despite revenue growth. The Andhra Pradesh-based company, with a market capitalisation of ₹135.00 crores, continues to grapple with margin compression that has plagued its operations throughout FY25. The stock has declined 23.71% over the past year, significantly underperforming both the Sensex and its chemicals sector peers, whilst trading at elevated valuations that raise serious questions about its investment merit.

Why is Jocil falling/rising?

2025-09-18 21:54:28

As of 18-Sep, Jocil Ltd's stock price is currently at 154.04, reflecting a decrease of 2.12, or 1.36%. The stock has underperformed its sector today by 0.86%, and it is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, Jocil has seen a return of -4.86%, while its performance over the last month is also negative at -3.91%. Despite a recent rise in delivery volume by 23.13%, the stock has experienced significant long-term challenges, including a decline in operating profit by an annual rate of -59.68% over the last five years and a return of -28.02% in the past year, indicating persistent underperformance against the benchmark. In the broader market context, Jocil's recent performance contrasts sharply with the Sensex, which has gained 1.67% over the past week and 2.20% over the past month. The stock's long-term growth prospects appear poor, as evidenced ...

View All News